Conditions: Schizophrenia
Keywords: Schizophrenia Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 180
Healthy volunteers: no

Brief summary:
A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia

Detailed description:
Study will evaluate the efficacy of a new compound versus placebo in the treatment of patients with schizophrenia (diagnosed by DSM-IV criteria) as measured by reductions from baseline on the total score of the Brief Psychiatric Rating Scale (BPRS) as extracted from the Positive and Negative Syndrome Scale (PANSS).

Arms:
arm 1: 80 mg AM dosing once daily arm 2: None

Interventions: intervention 1: Lurasidone intervention 2: Placebo
Intervention descriptions: intervention 1: 80 mg AM dosing once daily intervention 2: Matching Placebo to 40mg lurasidone tablets

Protocol document: